BIIB

Biogen News

Company Name Stock Ticker Symbol Market Type
Biogen Inc BIIB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.22 -1.03% 214.12 13:40:20
Open Price Low Price High Price Close Price Prev Close
215.79 213.37 216.61 216.34
more quote information »

Recent News

Date Time Source Heading
8/03/202219:32PRNUSEISAI PRESENTS NEW FINDINGS ON LECANEMAB'S INVESTIGATIONAL..
8/03/202217:41EDGARStatement of Changes in Beneficial Ownership (4)
8/01/202204:20TRMNBiogen (BIIB) Gets a Hold Rating from Mizuho Securities
7/29/202200:18TRMNRobert W. Baird Reaffirms Their Hold Rating on Biogen (BIIB)
7/29/202200:07TRMNSVB Securities Thinks Biogen’s Stock is Going to Recover
7/28/202207:30GLOBEThe New England Journal of Medicine Publishes Positive Phase..
7/28/202200:43TRMNBiogen Stock: Clinical Wins Support a Bullish Thesis
7/26/202208:32DJNBiogen Gets FDA Priority Review of Tofersen in Rare Form of..
7/26/202207:30GLOBEFDA Accepts Biogen’s New Drug Application and Grants..
7/22/202205:41TRMNJefferies Thinks Biogen’s Stock is Going to Recover
7/22/202205:16TRMNBiogen (BIIB) Gets a Buy Rating from SVB Securities
7/21/202223:51TRMNBiogen (BIIB) Gets a Hold Rating from Robert W. Baird
7/21/202208:24BNZGBenzinga Before The Bell: Baidu Beats Tesla, Finland Sells..
7/21/202202:19TRMNInvestors Frown Despite Biogen’s Decent Q2 Results, Improved..
7/20/202216:26EDGARQuarterly Report (10-q)
7/20/202215:09EDGARAmended Current Report Filing (8-k/a)
7/20/202207:05EDGARCurrent Report Filing (8-k)
7/20/202203:16TRMNKey Concerns Remain for Biogen Before Q2 Results, Says..
7/19/202206:55TRMNNeedham Reaffirms Their Buy Rating on Biogen (BIIB)
7/08/202221:48TRMNRBC Capital Keeps a Buy Rating on Biogen (BIIB)
7/06/202219:33EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202219:29EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202216:06EDGARPost-effective Amendment to Registration Statement (pos Am)
7/05/202223:05DJNEisai Shares Rise Sharply After U.S. FDA Grants Priority..
7/05/202219:30PRNUSTHE U.S. FDA ACCEPTS AND GRANTS PRIORITY REVIEW FOR EISAI'S..
6/22/202209:00BWBiogen and Happify Health Collaborate to Support Multiple..
6/21/202217:25EDGARCurrent Report Filing (8-k)
6/17/202217:17EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:15EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:14EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202217:01EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:33EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202216:29EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202207:30GLOBENew Data Presented at Cure SMA Reveal Residual Unmet Needs..
6/14/202207:30GLOBEThe Biogen Foundation and Community Lab Celebrates 20 Years..
6/10/202221:45TRMNAnalysts’ Opinions Are Mixed on These Healthcare Stocks:..
6/07/202216:38EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
6/06/202207:30GLOBEBiogen and Alectos Therapeutics Announce License and..
6/03/202208:00GLOBEBiogen and Bio-Thera Solutions Present Positive Phase 3 Data..
6/03/202205:20GLOBENew 12-Month Tofersen Data Presented at ENCALS Meeting Show..
6/02/202208:00GLOBEBiogen and Samsung Bioepis’ BYOOVIZ™ (ranibizumab-nuna)..
6/01/202207:21DJNSage, Biogen: Zuranolone Hits Key Goals in Postpartum..
5/31/202208:00GLOBEDenali Therapeutics and Biogen Announce Initiation of Phase..
5/27/202206:19EDGARNotice of Effectiveness (effect)
5/26/202216:51EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
5/25/202221:45TRMNRBC Capital Thinks Biogen’s Stock is Going to Recover
5/23/202208:10BNZGMorning Brief: Top Financial Stories Dominating on Monday,..
5/12/202212:38TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
5/09/202219:31PRNUSEISAI COMPLETES ROLLING SUBMISSION TO THE U.S. FDA FOR..
5/05/202207:30BWBiogen and MedRhythms to Develop and Commercialize a..


Your Recent History
NASDAQ
BIIB
Biogen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now